CXCR4-Specific Nanobodies as Potential Therapeutics for WHIM syndrome
Raymond H. de Wit(Vrije Universiteit Amsterdam), Martine J. Smit(Vrije Universiteit Amsterdam)
Cited by 33
Related Papers
Llama-derived Single Variable Domains (Nanobodies) Directed against Chemokine Receptor CXCR7 Reduce Head and Neck Cancer Cell Growth in Vivo
|Journal of Biological Chemistry|2013|143
Human cytomegalovirus encoded chemokine receptor US28 activates the HIF-1α/PKM2 axis in glioblastoma cells
|Oncotarget|2016|69
Targeting the latent human cytomegalovirus reservoir for T-cell-mediated killing with virus-specific nanobodies
|Nature Communications|2021|53
Selective targeting of ligand-dependent and -independent signaling by GPCR conformation-specific anti-US28 intrabodies
|Nature Communications|2021|37